SpeedElPharma.com
Title
Speedel- Speedel is a biopharmaceutical company that creates value for patients, partners and investors by developing innovative therapies for cardiovascular and metabolic diseases.
Contact
- Speedel Pharma AG (SPEEDELP83)
-
Description
Speedel is a biopharmaceutical company that creates value for patients, partners and investors by developing innovative therapies for cardiovascular and metabolic diseases.
Additional Information
Categories:
- Aliskiren
- Biopharmaceutical
- Biotech
- Biotechnology And Pharmaceuticals
- Business
- Cardiovascular Disease
- Cardiovascular Drug Development
- Chemistry
- Clinical Candidates
- Diabetes
- Drug Development
- Drug In Licensing
- Endothelin
- Endothelin A Receptor Antagonist
- Hypertension
- Innovation
- Innovative
- Lead Identification
- Lead Optimisation
- Leads
- Licensing
- Metabolic Disease
- Obesity
- Pharma
- Pharma Partnering
- Pharmaceuticals
- Protein Therapeutics
- Recombinant
- Renal
- Renin
- Renin Angiotensin System
- Renin Inhibition
- Research And Development
- Spp
- Spp100
- Spp200
- Spp301
- Spp500
- Spp600 Series
- Spp800 Series
- Small Molecules
- Spedel
- Speedel
- Speedel Experimenta
- Swiss Biotechnology
- Swiss Private Company
- Switzerland Biotechnology
- Biotechnology and Pharmaceuticals
- Drug In-licensing
- Research and Development
- SPP
- SPP100
- SPP200
- SPP301
- SPP500
- SPP600 Series
- SPP800 Series